News | October 16, 2024
Strides Pharma's CDMO arm OneSource raises Rs. 801 crore in pre-listing round
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
The share subscription agreements are being executed at a pre-money equity value of US$ 1.65 billion
Aims to achieve CDMO sales of US$ 400 million by 2028
Arco Lab now holds a 50% stake in Neviton
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
An interim analysis of this data shows no significant safety issues and a 91% seroconversion rate at Day 56.
Veeda Clinical Research will submit data in an application for Emergency Use Authorisation
Biolexis will also leverage the capabilities of Strides Group for launching this vaccine across regions where the group has a deep market presence and established relationships
They will commercialize molnupiravir in the international markets
He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
He will be stationed at the company HQ in Bengaluru, India
Subscribe To Our Newsletter & Stay Updated
